{
    "title": "U.S. Medicare limits coverage for Biogen's Alzheimer's drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10697757/U-S-Medicare-limits-coverage-Biogens-Alzheimers-drug.html",
    "date": "2022-04-07",
    "keywords": [
        "decision",
        "drug",
        "approval",
        "plan",
        "biogen",
        "medicare",
        "aduhelm",
        "access",
        "patient",
        "beasley",
        "government",
        "coverage",
        "cms",
        "administration",
        "decline",
        "use",
        "statement",
        "roche",
        "latestage",
        "fda",
        "trial",
        "wall",
        "street",
        "year",
        "phase",
        "iii",
        "health",
        "age",
        "policy",
        "medicaid",
        "medication",
        "review",
        "food",
        "june",
        "pathway",
        "ability",
        "plaque",
        "brain",
        "evidence",
        "assessment",
        "agency",
        "january",
        "business",
        "impact",
        "disease",
        "medicine",
        "action",
        "end",
        "outcome",
        "capital",
        "analyst",
        "research",
        "note",
        "ag",
        "co",
        "development",
        "process",
        "benefit",
        "comment",
        "product",
        "backlash",
        "pressure",
        "wider",
        "requirement",
        "population",
        "executive",
        "harry",
        "johns",
        "group",
        "month",
        "advertising",
        "campaign",
        "reporting",
        "deena",
        "editing",
        "adler",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}